Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial
Diabet. Med. 27, 965–967 (2010) Aims To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes. Methods Post hoc analysis of data from a randomized controlled trial of self‐management education for 824 individuals newly diagnosed with Type 2 diabetes. P...
Gespeichert in:
| Veröffentlicht in: | Diabetic medicine 2010-08, Vol.27 (8), p.965-967 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 967 |
|---|---|
| container_issue | 8 |
| container_start_page | 965 |
| container_title | Diabetic medicine |
| container_volume | 27 |
| creator | Skinner, T. C. Carey, M. E. Cradock, S. Dallosso, H. M. Daly, H. Davies, M. J. Doherty, Y. Heller, S. Khunti, K. Oliver, L. |
| description | Diabet. Med. 27, 965–967 (2010)
Aims To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes.
Methods Post hoc analysis of data from a randomized controlled trial of self‐management education for 824 individuals newly diagnosed with Type 2 diabetes. Participants completed the Depression scale of the Hospital Anxiety and Depression Scale after diagnosis and at 4, 8 and 12 months follow‐up. Participants also completed the Problem Areas in Diabetes scale at 8 and 12 months follow‐up. We present descriptive statistics on prevalence and persistence of depressive symptoms. Logistic regression is used to predict possible depression cases, and multiple regression to predict depressive symptomatology.
Results The prevalence of depressive symptoms in individuals recently diagnosed with diabetes (18–22% over the year) was not significantly different from normative data for the general population (12%) in the UK. Over 20% of participants indicated some degrees of depressive symptoms over the first year of living with Type 2 diabetes; these were mostly transient episodes, with 5% (1% severe) reporting having depressive symptoms throughout the year. At 12 months post diagnosis, after controlling for baseline depressive symptoms, diabetes‐specific emotional distress was predictive of depressive symptomatology.
Conclusions The increased prevalence of depressive symptoms in diabetes is not manifest until at least 1 year post diagnosis in this cohort. However, there are a significant number of people with persistent depressive symptoms in the early stages of diabetes, and diabetes‐specific distress may be contributing to subsequent development of depressive symptoms in people with Type 2 diabetes. |
| doi_str_mv | 10.1111/j.1464-5491.2010.03028.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_749018184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>749018184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4368-28337b8fa9ed89ed2759070417b9be2929c04512b471e3559bfcd99887c449ef3</originalsourceid><addsrcrecordid>eNqNkE2P0zAQhi0EYsvCX0C-IE4p_kpsI3GAbXdB6u4isQiJi-Wkk8UlaYonhebf45BSrliybI2fdzx6CKGczXlarzZzrgqV5cryuWCpyiQTZn54QGanh4dkxrQSmWSan5EniBvGuLDSPiZnghW51LmekfsF7CIghp9AcWh3fdciDVvafwNah4g9HcBHWseupevg77cdBqRdTe-GHVAx1kroAV_T1GXf9DihY3yx_HR9e7OgfQy-eUoe1b5BeHY8z8nny-XdxftsdXv14eLtKquULEwmjJS6NLW3sDZpC51bppniurQlCCtsxVTORak0B5nntqyrtbXG6EopC7U8Jy-nvrvY_dgD9q4NWEHT-C10e3RaWcYNNyqRZiKr2CFGqN0uhtbHwXHmRstu40aZbpTpRsvuj2V3SNHnx0_2ZQvrU_Cv1gS8OAIeK9_U0W-rgP84yQouhEzcm4n7FRoY_nsAt7hejreUz6Z8wB4Op7yP312h0yTuy82V-_rRXr6TQrmV_A1NxqXc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749018184</pqid></control><display><type>article</type><title>Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Skinner, T. C. ; Carey, M. E. ; Cradock, S. ; Dallosso, H. M. ; Daly, H. ; Davies, M. J. ; Doherty, Y. ; Heller, S. ; Khunti, K. ; Oliver, L.</creator><creatorcontrib>Skinner, T. C. ; Carey, M. E. ; Cradock, S. ; Dallosso, H. M. ; Daly, H. ; Davies, M. J. ; Doherty, Y. ; Heller, S. ; Khunti, K. ; Oliver, L. ; DESMOND Collaborative ; on behalf of The DESMOND Collaborative</creatorcontrib><description>Diabet. Med. 27, 965–967 (2010)
Aims To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes.
Methods Post hoc analysis of data from a randomized controlled trial of self‐management education for 824 individuals newly diagnosed with Type 2 diabetes. Participants completed the Depression scale of the Hospital Anxiety and Depression Scale after diagnosis and at 4, 8 and 12 months follow‐up. Participants also completed the Problem Areas in Diabetes scale at 8 and 12 months follow‐up. We present descriptive statistics on prevalence and persistence of depressive symptoms. Logistic regression is used to predict possible depression cases, and multiple regression to predict depressive symptomatology.
Results The prevalence of depressive symptoms in individuals recently diagnosed with diabetes (18–22% over the year) was not significantly different from normative data for the general population (12%) in the UK. Over 20% of participants indicated some degrees of depressive symptoms over the first year of living with Type 2 diabetes; these were mostly transient episodes, with 5% (1% severe) reporting having depressive symptoms throughout the year. At 12 months post diagnosis, after controlling for baseline depressive symptoms, diabetes‐specific emotional distress was predictive of depressive symptomatology.
Conclusions The increased prevalence of depressive symptoms in diabetes is not manifest until at least 1 year post diagnosis in this cohort. However, there are a significant number of people with persistent depressive symptoms in the early stages of diabetes, and diabetes‐specific distress may be contributing to subsequent development of depressive symptoms in people with Type 2 diabetes.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/j.1464-5491.2010.03028.x</identifier><identifier>PMID: 20653757</identifier><identifier>CODEN: DIMEEV</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anxiety ; Biological and medical sciences ; depression ; Depressive Disorder - diagnosis ; Depressive Disorder - psychology ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - psychology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Logistic Models ; Male ; Medical sciences ; Prevalence ; type 2 diabetes ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: endocrinology</subject><ispartof>Diabetic medicine, 2010-08, Vol.27 (8), p.965-967</ispartof><rights>2010 The Authors. Journal compilation © 2010 Diabetes UK</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4368-28337b8fa9ed89ed2759070417b9be2929c04512b471e3559bfcd99887c449ef3</citedby><cites>FETCH-LOGICAL-c4368-28337b8fa9ed89ed2759070417b9be2929c04512b471e3559bfcd99887c449ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1464-5491.2010.03028.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1464-5491.2010.03028.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23061223$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20653757$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skinner, T. C.</creatorcontrib><creatorcontrib>Carey, M. E.</creatorcontrib><creatorcontrib>Cradock, S.</creatorcontrib><creatorcontrib>Dallosso, H. M.</creatorcontrib><creatorcontrib>Daly, H.</creatorcontrib><creatorcontrib>Davies, M. J.</creatorcontrib><creatorcontrib>Doherty, Y.</creatorcontrib><creatorcontrib>Heller, S.</creatorcontrib><creatorcontrib>Khunti, K.</creatorcontrib><creatorcontrib>Oliver, L.</creatorcontrib><creatorcontrib>DESMOND Collaborative</creatorcontrib><creatorcontrib>on behalf of The DESMOND Collaborative</creatorcontrib><title>Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Diabet. Med. 27, 965–967 (2010)
Aims To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes.
Methods Post hoc analysis of data from a randomized controlled trial of self‐management education for 824 individuals newly diagnosed with Type 2 diabetes. Participants completed the Depression scale of the Hospital Anxiety and Depression Scale after diagnosis and at 4, 8 and 12 months follow‐up. Participants also completed the Problem Areas in Diabetes scale at 8 and 12 months follow‐up. We present descriptive statistics on prevalence and persistence of depressive symptoms. Logistic regression is used to predict possible depression cases, and multiple regression to predict depressive symptomatology.
Results The prevalence of depressive symptoms in individuals recently diagnosed with diabetes (18–22% over the year) was not significantly different from normative data for the general population (12%) in the UK. Over 20% of participants indicated some degrees of depressive symptoms over the first year of living with Type 2 diabetes; these were mostly transient episodes, with 5% (1% severe) reporting having depressive symptoms throughout the year. At 12 months post diagnosis, after controlling for baseline depressive symptoms, diabetes‐specific emotional distress was predictive of depressive symptomatology.
Conclusions The increased prevalence of depressive symptoms in diabetes is not manifest until at least 1 year post diagnosis in this cohort. However, there are a significant number of people with persistent depressive symptoms in the early stages of diabetes, and diabetes‐specific distress may be contributing to subsequent development of depressive symptoms in people with Type 2 diabetes.</description><subject>Anxiety</subject><subject>Biological and medical sciences</subject><subject>depression</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - psychology</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - psychology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Prevalence</subject><subject>type 2 diabetes</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vertebrates: endocrinology</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE2P0zAQhi0EYsvCX0C-IE4p_kpsI3GAbXdB6u4isQiJi-Wkk8UlaYonhebf45BSrliybI2fdzx6CKGczXlarzZzrgqV5cryuWCpyiQTZn54QGanh4dkxrQSmWSan5EniBvGuLDSPiZnghW51LmekfsF7CIghp9AcWh3fdciDVvafwNah4g9HcBHWseupevg77cdBqRdTe-GHVAx1kroAV_T1GXf9DihY3yx_HR9e7OgfQy-eUoe1b5BeHY8z8nny-XdxftsdXv14eLtKquULEwmjJS6NLW3sDZpC51bppniurQlCCtsxVTORak0B5nntqyrtbXG6EopC7U8Jy-nvrvY_dgD9q4NWEHT-C10e3RaWcYNNyqRZiKr2CFGqN0uhtbHwXHmRstu40aZbpTpRsvuj2V3SNHnx0_2ZQvrU_Cv1gS8OAIeK9_U0W-rgP84yQouhEzcm4n7FRoY_nsAt7hejreUz6Z8wB4Op7yP312h0yTuy82V-_rRXr6TQrmV_A1NxqXc</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Skinner, T. C.</creator><creator>Carey, M. E.</creator><creator>Cradock, S.</creator><creator>Dallosso, H. M.</creator><creator>Daly, H.</creator><creator>Davies, M. J.</creator><creator>Doherty, Y.</creator><creator>Heller, S.</creator><creator>Khunti, K.</creator><creator>Oliver, L.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201008</creationdate><title>Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial</title><author>Skinner, T. C. ; Carey, M. E. ; Cradock, S. ; Dallosso, H. M. ; Daly, H. ; Davies, M. J. ; Doherty, Y. ; Heller, S. ; Khunti, K. ; Oliver, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4368-28337b8fa9ed89ed2759070417b9be2929c04512b471e3559bfcd99887c449ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anxiety</topic><topic>Biological and medical sciences</topic><topic>depression</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - psychology</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - psychology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Prevalence</topic><topic>type 2 diabetes</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skinner, T. C.</creatorcontrib><creatorcontrib>Carey, M. E.</creatorcontrib><creatorcontrib>Cradock, S.</creatorcontrib><creatorcontrib>Dallosso, H. M.</creatorcontrib><creatorcontrib>Daly, H.</creatorcontrib><creatorcontrib>Davies, M. J.</creatorcontrib><creatorcontrib>Doherty, Y.</creatorcontrib><creatorcontrib>Heller, S.</creatorcontrib><creatorcontrib>Khunti, K.</creatorcontrib><creatorcontrib>Oliver, L.</creatorcontrib><creatorcontrib>DESMOND Collaborative</creatorcontrib><creatorcontrib>on behalf of The DESMOND Collaborative</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skinner, T. C.</au><au>Carey, M. E.</au><au>Cradock, S.</au><au>Dallosso, H. M.</au><au>Daly, H.</au><au>Davies, M. J.</au><au>Doherty, Y.</au><au>Heller, S.</au><au>Khunti, K.</au><au>Oliver, L.</au><aucorp>DESMOND Collaborative</aucorp><aucorp>on behalf of The DESMOND Collaborative</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2010-08</date><risdate>2010</risdate><volume>27</volume><issue>8</issue><spage>965</spage><epage>967</epage><pages>965-967</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><coden>DIMEEV</coden><abstract>Diabet. Med. 27, 965–967 (2010)
Aims To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes.
Methods Post hoc analysis of data from a randomized controlled trial of self‐management education for 824 individuals newly diagnosed with Type 2 diabetes. Participants completed the Depression scale of the Hospital Anxiety and Depression Scale after diagnosis and at 4, 8 and 12 months follow‐up. Participants also completed the Problem Areas in Diabetes scale at 8 and 12 months follow‐up. We present descriptive statistics on prevalence and persistence of depressive symptoms. Logistic regression is used to predict possible depression cases, and multiple regression to predict depressive symptomatology.
Results The prevalence of depressive symptoms in individuals recently diagnosed with diabetes (18–22% over the year) was not significantly different from normative data for the general population (12%) in the UK. Over 20% of participants indicated some degrees of depressive symptoms over the first year of living with Type 2 diabetes; these were mostly transient episodes, with 5% (1% severe) reporting having depressive symptoms throughout the year. At 12 months post diagnosis, after controlling for baseline depressive symptoms, diabetes‐specific emotional distress was predictive of depressive symptomatology.
Conclusions The increased prevalence of depressive symptoms in diabetes is not manifest until at least 1 year post diagnosis in this cohort. However, there are a significant number of people with persistent depressive symptoms in the early stages of diabetes, and diabetes‐specific distress may be contributing to subsequent development of depressive symptoms in people with Type 2 diabetes.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20653757</pmid><doi>10.1111/j.1464-5491.2010.03028.x</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0742-3071 |
| ispartof | Diabetic medicine, 2010-08, Vol.27 (8), p.965-967 |
| issn | 0742-3071 1464-5491 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_749018184 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Anxiety Biological and medical sciences depression Depressive Disorder - diagnosis Depressive Disorder - psychology Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - psychology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Humans Logistic Models Male Medical sciences Prevalence type 2 diabetes Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
| title | Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T07%3A53%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depressive%20symptoms%20in%20the%20first%20year%20from%20diagnosis%20of%20Type%202%20diabetes:%20results%20from%20the%20DESMOND%20trial&rft.jtitle=Diabetic%20medicine&rft.au=Skinner,%20T.%20C.&rft.aucorp=DESMOND%20Collaborative&rft.date=2010-08&rft.volume=27&rft.issue=8&rft.spage=965&rft.epage=967&rft.pages=965-967&rft.issn=0742-3071&rft.eissn=1464-5491&rft.coden=DIMEEV&rft_id=info:doi/10.1111/j.1464-5491.2010.03028.x&rft_dat=%3Cproquest_cross%3E749018184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749018184&rft_id=info:pmid/20653757&rfr_iscdi=true |